“Diagnostics and immunophenotyping monitoring of night paroxistic hemoglobinuria (pnh) and correlation with the efficacy of eculizumab treatment”, Acervo Saúde, no. 37, p. e1793, Dec. 2019, doi: 10.25248/reas.e1793.2019.